trending Market Intelligence /marketintelligence/en/news-insights/trending/ba0r1nve-n1w-aqgvrqjyq2 content esgSubNav
In This List

Biostage closes $1M private placement

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Biostage closes $1M private placement

Biostage Inc. closed a private placement of 302,115 common shares to raise $1 million in gross proceeds.

The stocks were sold at $3.31 apiece to Jinhui Liu.

Holliston, Mass.-based Biostage is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea.